EZH2 and melanoma: Thus, the reversal of an abnormal epigenetic landscape appears to be a promising therapeutic approach, such as in the case of EZH2 (Enhancer of Zeste Homologue 2; a histone methyltransferase) over-expression and its role in melanoma development and progression [5,6,7,8,9].